Statins as primary prevention in patients without dislipidaemia
Year: 2009
Type: article
Abstract: Cardiovascular disease (CVD) remains the leading cause ofdeath in Australia, responsible for 34% and 39% of maleand female deaths, respectively. It is also a significantcontributor to the burden of disease across the population,Dyslipidaemia, especially elevated levels of lOW-densitylipoprotein cholesterol (LDL-Cl, is recognised as a majorcardiovascular risk factor. Statins have become firmlyestablished as first-line lipid lowering therapy in thesecondary prevention of established CVD due to their abilityto lower LDL-C levels and improve patient outcomes
Source: UTAS Research Repository
Authors: L Stafford, Lre Bereznicki
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2141856630
